Gut Microbiome and Health: Early Parkinson’s Signs, Diversity Benefits, and Brain-Gut Connection Explained

Researchers have identified specific changes in the gut microbiome that may serve as early warning signs of Parkinson’s disease, potentially detectable years before motor symptoms appear. A study led by scientists at University College London (UCL) and published in Nature Medicine analyzed extensive metagenomic data and detailed clinical assessments to explore the link between intestinal bacteria and Parkinson’s risk. The findings suggest that alterations in the gut microbiota occur progressively, appearing in individuals at genetic risk and reaching their peak in those already diagnosed with the disease. Approximately 25% of the gut microbiome is consistently affected in Parkinson’s patients, with these changes correlating to the severity of both motor and non-motor symptoms. Researchers proposed a microbiome-based scoring system, called PDMS-16, to identify individuals at increased risk. This tool could help detect the disease long before clinical diagnosis, which typically occurs after more than 50% of dopamine-producing neurons have already been lost — highlighting the urgent need for early biomarkers. The study likewise found that people carrying genetic variants in the GBA1 gene, which are associated with a higher risk of developing Parkinson’s but do not yet present symptoms, have a gut microbiome similar to that of diagnosed patients. This supports the idea that gut changes may precede brain pathology, particularly in “body-first” forms of the disease, where neurodegeneration may begin in the enteric nervous system before spreading to the brain. To validate their findings, researchers evaluated intestinal microbiome samples from 271 Parkinson’s patients, 43 asymptomatic GBA1 variant carriers, and 150 healthy controls. These results were later confirmed in an additional cohort of 638 Parkinson’s patients and 319 healthy individuals from the UK, South Korea, and Turkey. Experts emphasize that the gut-brain axis plays a key role in initiating and spreading neurodegenerative processes. As Dr. Anthony Schapira, co-lead author and professor at UCL Queen Square Institute of Neurology, stated, gut microbes may reveal early signs of Parkinson’s and serve as an early warning signal — potentially years before symptoms emerge. These insights could inform future strategies for early detection and intervention, offering recent hope for addressing one of the world’s fastest-growing neurodegenerative disorders. Parkinson’s disease remains the second most common neurodegenerative condition in the United States after Alzheimer’s, affecting over a million people nationwide. Given that neurological damage is often significant by the time motor symptoms become evident, identifying preclinical signs through microbiome analysis may improve outcomes by enabling earlier therapeutic approaches.